AI-generated summary
The authors studied whether infrared low-level laser photobiomodulation could modulate acute lung injury in 24 male Wistar rats, a model meant to resemble a complication of COVID-19. They report that treated rats showed fewer inflammatory infiltrates, less alveolar septal thickening, a lower lung injury score and lower IL-1β expression than untreated injured rats. The findings come from an experimental animal study.
- Participants
- 24
- Who or what was studied
- 24 male Wistar rats randomly allocated to three groups of eight: control, acute lung injury, and acute lung injury with photobiomodulation.
- Wavelengths
- 808 nm
- Limits stated in the abstract
- The study is a small experimental rat model, so the results may not apply to humans with COVID-19.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 808 nm
- Total energy
- 1.68 J
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Laser, Low-level laser therapy, Control group. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.